ArticleCirculation. Genomic and precision medicine2026
Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A Mendelian Randomization Study.
Subbaramireddy Remala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.